Total GHG emissions
Unit
Indicator
Metric type
Framework alignment notes
ESRS E1-6 44 AR 39
CDP 7.6, 7.7, 7.8, 7.12.1, 7.15, 7.15.1, 7.16, 7.17, 7.17.1, 7.17.2, 7.17.3, 7.19, 7.20.1, 7.20.2, 7.20.3, 7.21, 7.22, 7.23.1, 7.45
GRI 305-1-a, GRI 305-1-b, GRI 305-1-c, GRI 305-2-a, GRI 305-2-b, GRI 305-2-c, GRI 305-3-a, GRI 305-3-b, GRI 305-3-c
SBTN: GHG emissions
Refer to the PSCI resources included in the Metric definition and specification column
Refer to the PSCI's Decarbonization Playbook for the Pharmaceutical Industry and Supplier Environmental Survey for alignment to the metric
Refer to EFPIA's Clear Steps Toward a Greener Future - Pharmaceutical Sector’s Environmental Sustainability Statement (10.06.24) for alignment to metric
GBF Target 8
Target example
[Company name] commits to reduce [Scope 1, 2, 3, or total] emissions by [target amount, in absolute metric tonnes of CO2eq, or percentage] by [target date] compared to a [baseline year] baseline.
Target source: WBCSD target template
Sector
Value chain stage
Raw Materials
Manufacturing
End of Life
Metric assessment
Relevance: High
Feasibility: High